Important Update on Weight Loss Treatment

From Monday 23 June, a new NHS-approved treatment called tirzepatide (Mounjaro®) will begin to be available in some GP settings.

This is only for patients with a BMI over 40 and four or more obesity-related conditions (such as type 2 diabetes or high blood pressure). Access will be prioritised for those with the greatest clinical need.

Please note: GPs will not be prescribing this immediately, and patients are kindly asked not to contact the surgery to request it. Eligible patients may be contacted over time to discuss it further.

We continue to encourage all patients to explore NHS-supported healthy lifestyle services as part of their weight loss journey.

Find out more here:
https://bsw.icb.nhs.uk/information-for-patients-on-availability-of-new-weight-loss-treatment/